Building a Stronger & Better AngioDynamics

In this episode of Let's Talk Medtech, AngioDynamics CEO James Clemmer shares insights into what has been a transformative year for the medical device company across multiple therapeutic areas.Clemmer highlighted several significant achievements that have strengthened the company's position in both oncology and vascular care. He also describes how a crucial pivot helped redefine AngioDynamics.

MD+DI Senior Editor Amanda Pedersen breaks down the most significant mid-year trends shaping the medical device industry in this insightful episode of Let's Talk Medtech. Get her expert analysis on market developments, regulatory changes, and emerging technologies that are transforming healthcare innovation.Whether you're a medical device professional, healthcare provider, or industry investor, this episode delivers valuable insights to help you navigate the evolving medtech landscape. Subscribe for regular updates on industry news, expert interviews, and in-depth analysis of the technologies revolutionizing patient care.

In a significant industry move this February, Baxter completed the sale of its kidney care business to The Carlyle Group, creating Vantive—a company now experiencing a unique balance of established expertise and newfound agility.CEO Chris Toth recently shared Vantive's ambitious vision, highlighting the firm's commitment to investing over $1 billion in digitally-enabled kidney care solutions. Toth discussed how this strategic separation has empowered the company to maintain its valuable legacy while gaining the flexibility to execute decisions more rapidly.During the conversation, Toth also offered personal insights into his role as a medtech CEO and shared his deep passion for Vantive's mission to transform kidney care.

In this insightful podcast episode, Dr. Martha Morrell, CMO of NeuroPace, shares her transformative journey from academia to pioneering a revolutionary treatment for epilepsy. The RNS System, inspired by cardiac devices, offers targeted stimulation to the brain, tailoring interventions to each patient's needs. Dr. Morrell discusses the challenges and triumphs of steering such an innovation to FDA approval. Her story highlights the intersection of expertise, perseverance, and multi-disciplinary collaboration in MedTech, setting a new precedent for epilepsy treatment.

Peter Shen leads the Digital & Automation business at Siemens Healthineers North America. With over 25 years of experience in healthcare digitalization, he has held several executive management roles across sales, marketing, and innovation, with a focus on driving the adoption of new and emerging technologies. Notably, Peter has testified before Congress multiple times, advocating for the benefits of AI and championing new federal healthcare reimbursement policies. Find out what he has to say about Siemens Healthineers using AI to help enrich patients’ lives in this all-new episode of Let’s Talk Medtech.

In this episode of Let's Talk MedTech, Omar chats with Jijo James, Chief Medical Officer for Johnson & Johnson MedTech and Interventional Oncology. James shares insights into J&J's commitment to patient safety, discussing how the company combines clinical safety, safety science, and bioethics to ensure safe and effective outcomes for patients. He highlights the importance of the operator in medical device procedures and how J&J is improving safety through innovative tools like the device briefing tool. James also discusses the challenges of device-related interruptions during surgeries, emphasizing the need for better communication and proactive strategies to avoid complications. This is a fascinating conversation for anyone interested in healthcare innovation and patient safety in the medtech industry!

Ha Hong, Chief AI Officer at Medtronic Endoscopy, joins us to talk about how the company is embracing artificial intelligence. He'll also discuss the trends he's seeing with AI in the medical device industry on this brand-new episode of Let's Talk Medtech.

Jennifer Samproni, CTO of Flex, discusses the importance of human-machine interface innovation and strategies for medical device designers and manufacturers.

EY’s John Babbitt and Jim Welch join us for this episode to dive deeply into the Pulse of the Medtech Industry Report. We’re talking about deals, IPOs, the hottest segments, and more in this incredible episode of Let’s Talk Medtech.

Interested in designing medical device products? Want to know the do's and dont's of medtech design? Then you must listen to this all-new episode of Let's Talk Medtech featuring BlackHägen Design's Philip Remedios and Renee Bailey. Both will talk about what you need to have in mind when building device and breakdown how Contextual Inquiry is changing how we think about medtech design.